LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    2 UK shares to buy now for growth

    From his list of top UK shares to buy now for his portfolio, our writer considers two firms whose growth…

    Read more »

    Investing Articles

    AstraZeneca (AZN) shares gain on acquisition news

    AstraZeneca (LON: AZN) expands its presence in rare disease development with a further acquisition, sending its shares higher.

    Read more »

    Syringe and vial on blue background
    Investing Articles

    The Oxford Biomedica share price has doubled since signing its Covid-19 vaccine deal. Can the momentum continue?

    Oxford Biomedica’s share price is soaring. But is this simply the hype of its Covid-19 vaccine deal? Megan Boxall examines…

    Read more »

    Investing Articles

    2 FTSE 100 stocks to buy in a market crash

    As the FTSE 100 continues to fall, Charlie Keough looks at two stocks he would add to his portfolio should…

    Read more »

    Investing Articles

    Why is the AstraZeneca (LON: AZN) share price climbing?

    The AstraZeneca share price (LON: AZN) had started to slip back a bit. But a big jump on Monday has…

    Read more »

    Investing Articles

    FTSE 100: 2 stocks to buy in a market slump

    With fears of a market crash, I think buying the dip is the way to go. These two FTSE 100…

    Read more »

    Investing Articles

    2 of the best FTSE 100 stocks to buy today

    The FTSE 100 index is in the red today, but not all stocks are doing badly. These two, for instance,…

    Read more »

    Investing Articles

    The AstraZeneca (AZN) share price is soaring: here’s what I’d do now

    Growing drugs development success has helped lift the AstraZeneca (LON: AZN) share price, but would I buy now? For me,…

    Read more »

    Investing Articles

    Why I’d buy AstraZeneca shares in September

    AstraZeneca shares dropped last week. Suraj Radhakrishnan analyses if this presents a buying opportunity in the long term.

    Read more »

    Syringe and vial on blue background
    Investing Articles

    The US economy could slow down. Here’s what I’d do

    Latest forecasts have cut the US economy's outlook, which could have implications for stock markets around the world. Here's what…

    Read more »

    Investing Articles

    As the FTSE 100 plunges, I’d buy these stocks

    The FTSE 100 is slumping today, but Rupert Hargreaves thinks this could be a great opportunity to buy these stocks…

    Read more »

    Investing Articles

    Why I’d buy these 2 UK shares today for long-term growth

    As many predict a solid bounce-back for the UK economy, Charlie Keough looks at two UK shares he would buy…

    Read more »